Faeth Therapeutics, Inc. Other Non-Current Liabilities
Faeth Therapeutics, Inc. (FTH) had Other Non-Current Liabilities of $1.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-04
- 2026-06-30: Other Liabilities, Noncurrent $1.00K.
- 2026-03-31: Other Liabilities, Noncurrent $1.00K.
- 2025-12-31: Other Liabilities, Noncurrent $0.00.
- 2024-06-30: Other Liabilities, Noncurrent $67.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-04 | |
| 2024-06-30 | $67.00K 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $68.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $67.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $67.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $72.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $34.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $149.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $777.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $109.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $182.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $52.00K 10-K · filed 2022-03-15 | $138.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |